Lorlatinib side effects

Lorlatinib (Lorlatinib) is a targeted drug used to treat non-small cell lung cancer (NSCLC). It is mainly used to treat patients with positive mutations of ALK (tyrosine kinase) and ROS1. Although lorlatinib is highly effective in treating these cancer types, like many drugs, it may come with some side effects. Here is more information about the possible side effects of lorlatinib:

1. Fatigue (Fatigue): Fatigue is one of the most common side effects of lorlatinib. Patients may experience extreme fatigue and weakness, affecting daily life and activities. Patients are advised to get adequate rest and discuss medication dosage adjustments with their doctor as needed.

2. Cough (Cough): Cough is another common side effect and is usually mild. If the cough becomes severe or is accompanied by other uncomfortable symptoms, such as sputum production or shortness of breath, patients should consult a doctor promptly.

3. Shortness of BreathShortness of Breath: Some patients may experience shortness of breath while taking lorlatinib. This may require professional medical evaluation, as severe shortness of breath may be a sign of lung problems.

4. Nausea (Nausea) and vomiting (Vomiting): Lorlatinib may cause mild nausea and vomiting. These symptoms can usually be relieved by taking medication after meals or using anti-nausea medications. If nausea and vomiting persist or worsen, patients should consult their doctor.

5. Headache (Headache): Some patients may experience headache while taking lorlatinib. This is usually mild and can be relieved with rest and over-the-counter medications.

6. Constipation (Constipation) and diarrhea (Diarrhea): Lorlatinib can also cause intestinal problems, including constipation and diarrhea. Patients can manage these problems with diet and medication, but if they persist, they should consult a doctor.

7. Visual Disturbances (Visual Disturbances): Some patients report visual disturbances, such as blurred vision, halos, flickers, etc. while using lorlatinib. These symptoms are usually temporary, but patients should tell their doctor immediately to rule out the risk of vision problems.

8. Hypertension (Hypertension): Lorlatinib may cause high blood pressure. During treatment, the patient's blood pressure should be monitored frequently, and medications should be taken to control high blood pressure if necessary.

9. Cough and Risk of Pneumonia: When using lorlatinib, patients may develop cough and sputum production, which may be early symptoms of pneumonia. Therefore, respiratory symptoms require close monitoring to ensure early treatment.

10. Elevated Liver Enzymes (Elevated Liver Enzymes): Lorlatinib may cause abnormal liver function, manifested by elevated liver enzymes. Doctors usually monitor this condition by regularly checking a patient's liver function.

It is important to emphasize that the side effects of lorlatinib may vary among individuals, and not all patients will experience all side effects. It is important that patients work closely with their doctor while using lorlatinib, with regular check-ups and monitoring to ensure optimal treatment results and to promptly manage any side effects. Effective communication and collaboration during treatment will help minimize side effects and increase the success rate of treatment.

Lorlatinib has been launched in China and is included in medical insurance. Patients can purchase it domestically, but the price is relatively high, about 10,000 to 20,000 yuan. For details, please consult the local hospital pharmacy. There are original drugs and cheaper generic drugs abroad. The cheaper ones are the original drugs from Turkey, which cost more than 1,000 yuan, and the original drugs from Hong Kong, China, which cost about 30,000 yuan. Generic drugs are mainly generic drugs from Laos and Bangladesh. The price is about several thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.